Cite
HARVARD Citation
Moore, D. et al. (2020). Mogamulizumab: An Anti-CC Chemokine Receptor 4 Antibody for T-Cell Lymphomas. Annals of pharmacotherapy. 54 (4), pp. 371-379. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Moore, D. et al. (2020). Mogamulizumab: An Anti-CC Chemokine Receptor 4 Antibody for T-Cell Lymphomas. Annals of pharmacotherapy. 54 (4), pp. 371-379. [Online].